Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, the Johnson & Johnson Innovation team is looking to present its external collaboration model and meet life sciences start-ups across Europe through virtual events and 1:1 sessions. The first such virtual event will target the Swiss ecosystem. The event will include an open briefing on the Johnson & Johnson Innovation model on May 27, followed by one-to-one partnering meetings with selected companies on May 27 and 28.
Exciting races and challenging tasks for pilots and spectators
CPhI Worldwide is a highlight of the pharma calendar uniting pharma professionals and suppliers from around the world.